BURLINGTON, Mass.– Butterfly Network has appointed Arun Nagdev, M.D., as Chief Medical Officer for Point-of-Care Ultrasound (POCUS), strengthening its clinical leadership as the company expands its global ultrasound strategy.
In the role, Dr. Nagdev will lead global medical strategy for Butterfly’s core POCUS business, focusing on clinical product validation, customer engagement, and regulatory and clinical development efforts.
Dr. Nagdev brings more than two decades of experience advancing the adoption, education, and clinical standards of point-of-care ultrasound worldwide. He currently serves as an attending physician and Director of Emergency Ultrasound at Highland General Hospital, and as an Associate Clinical Professor of Emergency Medicine at the University of California, San Francisco. He has also held leadership positions with major professional organizations, including the American College of Emergency Physicians and the American Institute of Ultrasound in Medicine.
Beyond his clinical and academic roles, Dr. Nagdev has worked extensively at the intersection of ultrasound technology, artificial intelligence, and product development. He previously served as Vice President of Clinical at Exo and has advised imaging companies such as Philips and Fujifilm SonoSite. He is also a widely published researcher and educator with numerous peer-reviewed studies and international presentations.
“Arun is one of the most respected voices in point-of-care ultrasound, with a rare combination of clinical credibility, academic leadership, and product insight,” said Joseph DeVivo, President, CEO, and Chairman of Butterfly Network. “As we continue to scale our enterprise strategy and expand globally, his leadership will be critical to ensuring our technology delivers measurable clinical and economic value for customers.”
“Butterfly has fundamentally changed what’s possible with ultrasound through its semiconductor-based, software-defined platform,” said Dr. Nagdev. “I’m excited to join at a time when point-of-care ultrasound is becoming essential to care delivery across settings. The next phase will be defined by clinical standards and broader adoption, and I look forward to supporting that progression globally.”
